Numaferm Revenue and Competitors
Estimated Revenue & Valuation
- Numaferm's estimated annual revenue is currently $2.4M per year.
- Numaferm's estimated revenue per employee is $98,000
Employee Data
- Numaferm has 24 Employees.
- Numaferm grew their employee count by -4% last year.
Numaferm's People
Name | Title | Email/Phone |
---|
Numaferm Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 19 | -24% | N/A | N/A |
#2 | $18.3M | 131 | 18% | N/A | N/A |
#3 | $1.6M | 19 | 0% | N/A | N/A |
#4 | $62.8M | 359 | 11% | N/A | N/A |
#5 | $5.2M | 46 | -16% | N/A | N/A |
#6 | $14M | 100 | -7% | N/A | N/A |
#7 | $18.8M | 134 | -20% | $70M | N/A |
#8 | $2.5M | 26 | 8% | N/A | N/A |
#9 | $0.9M | 11 | -8% | N/A | N/A |
#10 | $12.5M | 89 | 46% | N/A | N/A |
What Is Numaferm?
We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
keywords:N/AN/A
Total Funding
24
Number of Employees
$2.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Numaferm News
2022-04-06 - The peptide therapeutics contract API manufacturing market is ...
... Philipp Burling (Chief Financial Officer, NUMAFERM). The research includes detailed profiles of key service providers (listed below)...
2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...
... NSJ Prayog Life Sciences; NUMAFERM; ONL Therapeutics; OPKO Health; Oramed Pharmaceuticals; ORPEGEN Peptide Chemicals; Oryn Therapeutics...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.1M | 27 | 8% | N/A |
#2 | $5.3M | 28 | -24% | N/A |
#3 | $5.3M | 28 | -24% | N/A |
#4 | $8M | 32 | 10% | N/A |
#5 | $3.8M | 33 | -38% | N/A |